Menu
Scroll to top

David Hardaker

Reporter

David Hardaker — Reporter

David has an extensive career as a journalist and broadcaster, primarily at the ABC where he worked on flagship programs such as Four Corners, The 7.30 Report, Foreign Correspondent, AM and PM. He spent eight years reporting in the Middle East and can speak Arabic.

Winning the hearts, minds (and pockets) of doctors

Winning the hearts, minds (and pockets) of doctors

If Novo Nordisk is to fulfil the potential of its anti-obesity drug Saxenda, it needs more doctors to have a new understanding of how obesity really works. And to prescribe. Again and again.

The commercial bet on obesity designed to ‘create the market’

The commercial bet on obesity designed to ‘create the market’

The race to find a pharmacological way to combat obesity is on — and in addition to financial pressures, it has proven devilishly difficult to make an obesity drug that is effective, safe and works at scale, across a population.

Is obesity a 'disease'? And, if it is, who wins?

Is obesity a 'disease'? And, if it is, who wins?

Getting doctors and medical bodies to classify obesity as a 'disease' would be a huge win for pharmaceutical companies. Here's how they're trying to do just that.

Obesity, politics, money and a company called Novo Nordisk

Obesity, politics, money and a company called Novo Nordisk

Novo Nordisk wants to change the way Australians think about obesity. And if it is successful, it could make a killing.